Anthracis Real-Time Pcr Assay
Assay, Nucleic Acid Amplification, Bacillus Anthracis. 510(k) K140426, from Centers For Disease Control and Prevention (CDC) (Atlanta, GA). Product code NHT, class 2.
As of Nov 17, 2026, K140426 is an FDA 510(k) held by Centers For Disease Control and Prevention (CDC), substantially equivalent on May 22, 2014 after 92 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: May 22, 2014
- Review time: 92 days
- Recalls: 0
- Cited as a predicate by: 1 device
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe B. anthracis Real-Time PCR Assay is an in vitro diagnostic test for the qualitative detection of plasmid and chromosomal DNA sequences from B. anthracis. The assay can be used to test human respiratory samples, whole blood, serum, plasma, swabs from lesions, CSF, pleural fluid, and bacterial culture isolates from individuals suspected of having anthrax.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Jbaids Anthrac Detection SystemK051713 · Idaho Technology, Inc. · Nov 18, 2005
- Modification To Jbaids Anthrax Detection SystemK071188 · Idaho Technology, Inc. · May 21, 2007
Cited as a Predicate
1 later 510(k) summary names this device as a predicate- B. anthracis Real-time PCR AssayK192871 · Centers for Disease Control and Prevention · Nov 7, 2019
Other NHT Clearances
The newest 510(k)s for the same product code; see every NHT device- B. anthracis Real-time PCR AssayK262368 · Centers for Disease Control and Prevention · Oct 7, 2026
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 19, 2014
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3045
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files